Skip Ribbon Commands
Skip to main content

​​​​​​​​

​​

Primary Diagnosis

Wound(s)

S​tudy Purpose

To assess the effectiveness of PuraPly™AM in real-world clinical settings, as measured by: Percent reduction in wound area, time to complete wound closure (if closure occurs), and improvement in wound bed condition.

Principal Investigator: Damien Dauphinee, DPM

Trial Details

Locations: The Heart Hospital Baylor Denton

Sponsor: Organogenesis

IRB Number: 017-486

Trial Status: Enrolling

Exclusions: Adults only

Change in Care: None

Contact Information:

Lucy Miranda
469.814.4727
Lucy.Miranda@BSWHealth.org

Full Protocol Title

Real-World Effectiveness Study of PuraPly™AM on Wounds (The RESPOND Registry)

Get Detailed I​nfor​mation O​n Clinicaltrials.gov »​​​​​​​​​​​​​​​​​​​​​​​​

​​

​​

​​​​​​​​​​BAYLOR SCOTT & WHITE RESEARCH ​INSTITUTE​​